These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22972760)

  • 1. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuation rates of levetiracetam in children from the EULEVp cohort study.
    Dureau-Pournin C; Pédespan JM; Droz-Perroteau C; Lavernhe G; Mann M; Pollet C; Robinson P; Jové J; Moore N; Fourrier-Réglat A;
    Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience.
    Leppik I; De Rue K; Edrich P; Perucca E
    Epileptic Disord; 2006 Jun; 8(2):118-30. PubMed ID: 16793573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam may favorably affect seizure outcome after temporal lobectomy.
    Jehi LE; Irwin AI; Kayyali H; Vadera S; Bingaman W; Najm I
    Epilepsia; 2012 Jun; 53(6):979-86. PubMed ID: 22462729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.
    Droz-Perroteau C; Dureau-Pournin C; Vespignani H; Marchal C; Blin P; Blazejewski S; Pollet C; Jové J; Robinson P; Moore N; Fourrier-Réglat A;
    Br J Clin Pharmacol; 2011 Jan; 71(1):121-7. PubMed ID: 21143508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
    Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
    Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
    Kang BS; Moon HJ; Kim YS; Lee ST; Jung KH; Chu K; Lee SK
    Epileptic Disord; 2013 Sep; 15(3):302-10. PubMed ID: 23981665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
    López-Góngora M; Martínez-Domeño A; García C; Escartín A
    Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS; Benatar M
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of levetiracetam for partial seizures.
    Abou-Khalil B; Schaich L
    Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of levetiracetam efficacy in epileptic syndromes with continuous spikes-waves during slow sleep.
    Atkins M; Nikanorova M
    Seizure; 2011 Oct; 20(8):635-9. PubMed ID: 21752673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.